Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer

References

• IonovYPeinadoMAMalkhosyanSShibataDPeruchoMUbiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesisNature199336364295585618505985
   PubMed Web of Science ®Google Scholar
• ThibodeauSNBrenGSchaidDMicrosatellite instability in cancer of the proximal colonScience199326051098168198484122
   PubMed Web of Science ®Google Scholar
• CarethersJMStoffelEMLynch syndrome and Lynch syndrome mimics: the growing complex landscape of hereditary colon cancerWorld J Gastroenterol201521319253926126309352
   PubMed Web of Science ®Google Scholar
• CarethersJMDifferentiating Lynch-like from Lynch syndromeGastroenterology2014146360260424468183
   PubMed Web of Science ®Google Scholar
• StoffelEMKastrinosFFamilial colorectal cancer, beyond Lynch syndromeClin Gastroenterol Hepatol20141271059106823962553
   PubMed Web of Science ®Google Scholar
• GradyWMCarethersJMGenomic and epigenetic instability in colorectal cancer pathogenesisGastroenterology200813541079109918773902
   PubMed Web of Science ®Google Scholar
• HampelHFrankelWLMartinEScreening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)N Engl J Med2005352181851186015872200
   PubMed Web of Science ®Google Scholar
• WellsKWisePEHereditary colorectal cancer syndromesSurg Clin North Am201797360562528501250
   PubMed Web of Science ®Google Scholar
• KheirelseidEAMillerNChangKHMismatch repair protein expression in colorectal cancerJ Gastrointest Oncol20134439740824294512
   PubMedGoogle Scholar
• DudleyJCLinMTLeDTEshlemanJRMicrosatellite instability as a biomarker for PD-1 blockadeClin Cancer Res201622481382026880610
   PubMed Web of Science ®Google Scholar
• JenkinsMABagliettoLDowtyJGCancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family studyClin Gastroenterol Hepatol20064448949816616355
   PubMed Web of Science ®Google Scholar
• BolandCRKoiMChangDKCarethersJMThe biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedsideFam Cancer200871415217636426
   PubMed Web of Science ®Google Scholar
• HampelHFrankelWPanescuJScreening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patientsCancer Res200666157810781716885385
   PubMed Web of Science ®Google Scholar
• RossiBMPalmeroEILópez-KostnerFA survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin AmericaBMC Cancer201717162328874130
   PubMed Web of Science ®Google Scholar
• StoffelEMHeritable gastrointestinal cancer syndromesGastroenterol Clin North Am201645350952727546846
   PubMed Web of Science ®Google Scholar
• KobayashiHOhnoSSasakiYMatsuuraMHereditary breast and ovarian cancer susceptibility genes (review)Oncol Rep20133031019102923779253
   PubMed Web of Science ®Google Scholar
• JärvinenHJAarnioMMustonenHControlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancerGastroenterology2000118582983410784581
   PubMed Web of Science ®Google Scholar
• JiricnyJReplication errors: cha(lle)nging the genomeEMBO J19981722642764369822589
   PubMed Web of Science ®Google Scholar
• HeinemannVvon WeikersthalLFDeckerTFOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trialLancet Oncol201415101065107525088940
   PubMed Web of Science ®Google Scholar
• CremoliniCLoupakisFFalconeAFOLFOXIRI and bevacizumab for metastatic colorectal cancerN Engl J Med20153723291292
   Google Scholar
• MahipalAGrotheyARole of biologics in first-line treatment of colorectal cancerJ Oncol Pract201612121219122827943689
   PubMed Web of Science ®Google Scholar
• van CutsemECervantesAAdamRESMO consensus guidelines for the management of patients with metastatic colorectal cancerAnn Oncol20162781386142227380959
   PubMed Web of Science ®Google Scholar
• HodiFSO’DaySJMcdermottDFImproved survival with ipilimumab in patients with metastatic melanomaN Engl J Med2010363871172320525992
   PubMed Web of Science ®Google Scholar
• BrahmerJRPD-1-targeted immunotherapy: recent clinical findingsClin Adv Hematol Oncol2012101067467523187774
   PubMedGoogle Scholar
• JanakiramMPareekVChengHNarasimhuluDMZangXImmune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignanciesImmunotherapy20168780981927349980
   PubMed Web of Science ®Google Scholar
• LeeVMurphyALeDTDiazLAMismatch repair deficiency and response to immune checkpoint blockadeOncologist201621101200121127412392
   PubMed Web of Science ®Google Scholar
• LeDTDurhamJNSmithKNMismatch repair deficiency predicts response of solid tumors to PD-1 blockadeScience2017357634940941328596308
   PubMed Web of Science ®Google Scholar
• KielerMScheithauerWZielinskiCCChottAAl-MukhtarAPragerGWCase report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky diseaseESMO Open201616e00008428255450
   PubMedGoogle Scholar
• LeDTUramJNWangHPD-1 blockade in tumors with mismatch-repair deficiencyN Engl J Med2015372262509252026028255
   PubMed Web of Science ®Google Scholar
• LeeVLeDTEfficacy of PD-1 blockade in tumors with MMR deficiencyImmunotherapy2016811326643016
   PubMed Web of Science ®Google Scholar
• BarnetsonRATenesaAFarringtonSMIdentification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancerN Engl J Med2006354262751276316807412
   PubMed Web of Science ®Google Scholar
• UmarABolandCRTerdimanJPRevised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityJ Natl Cancer Inst200496426126814970275
   PubMed Web of Science ®Google Scholar
• LigtenbergMJKuiperRPChanTLHeritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1Nat Genet200941111211719098912
   PubMed Web of Science ®Google Scholar
• KempersMJKuiperRPOckeloenCWRisk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort studyLancet Oncol2011121495521145788
   PubMed Web of Science ®Google Scholar
• GatalicaZSnyderCManeyTProgrammed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer typeCancer Epidemiol Biomarkers Prev201423122965297025392179
   PubMed Web of Science ®Google Scholar